StudentShare
Contact Us
Sign In / Sign Up for FREE
Search
Go to advanced search...
Free

Brachy therapy for prostate cancer - Essay Example

Cite this document
Summary
This essay "Brachy therapy for prostate cancer" is focused on the means of prostate cancer curing. It is mentioned that the need to have a therapy that would cater for prostate cancer became necessary when medical treatment seemed obviously unworkable…
Download full paper File format: .doc, available for editing
GRAB THE BEST PAPER94.4% of users find it useful
Brachy therapy for prostate cancer
Read Text Preview

Extract of sample "Brachy therapy for prostate cancer"

Brachy Therapy for Pro Cancer (Literature Review) Overview of Brachytherapy for Prostrate Cancer The need to have a therapy that would cater for prostrate cancer became necessary when medical treatment seemed obviously unworkable for scientists who worked their way to getting a cure for prostrate cancer. Writing on Brachytherapy as a medical therapy, Hoskin et al (2007) explain that has to do with “Brachytherapy is well established as a treatment for localised prostate cancer.” This means that branchytherapy has its basis from radioactive seed implantation therapy. The kind of dose needed for the treatment of a particular cancer case is dependent on several factors as Pieters et al (2009) explain that “the treatment of intermediate to high-risk prostate cancer with radiotherapy high doses are needed for high tumor control.” The use of branchytherapy for the treatment of prostrate cancer has been through a lot of evolutions. Primarily, researchers have looked at the effect of using the therapy alone as against using it together with other external medical aids. The evolution did not however happen without any challenges as the early days of the invention was characterized with dampened morale and enthusiasm to integrate the therapy to regular medical practice. Indications with the use of Brachytherapy Like all other scientific and medical discoveries, the use of brachytherapy has been taken through several empirical and evidence based protocols to proof the authenticity of the brachytherapy for the treatment and care of prostrate cancer. Such indications have brought about a number of interesting facts, findings and conclusions about brachytherapy. For instance in 2008, the Agency for Healthcare Research and Quality (AHRQ) conducted a research, which concluded that no randomized controlled trials had compared brachytherapy alone with other existing treatment options for clinically restricted prostate cancer treatment (Agency for Healthcare Research and Quality, 2008). There has also being controversial discussions on the dose of treatment. For instance in their research findings, Pieters (2006) et al reported that “high dose radiotherapyis necessary to control prostate cancer, especially in intermediate and high risk cancers.” This is not withstanding of the fact that the same research concluded that “increasing dose with external beam radiotherapy leads to a higher risk of normal tissue damage.” Variations in the indications for the use of brachytheraphy emanates from differences in research modalities. For instance Pieters et al (2008) made a revelation on the α/β ration used for prostrate. Their research found that “modeling studies suggest that the α/β -ratio for prostate could be as low as 1.5 Gy, while other studies show higher α/β –ratios” (Pieters, 2008). Presently, patients who receive treatment with brachytherapy are patients with stage T1-T2a, PSA level of 10 ng/mL or less, and Gleason score of 6 or lower in this category. Most of these patients are treated with brachytherapy along with no other form of treatment. Even with the brachytherapy, Theodorescu (2011) notes that “the recommended prescription doses for monotherapy are 145 Gy for iodine (I)–125 and 120-125 Gy for palladium (Pd)–103.” Efficacy of the use of brachytherapy with an without external therapy The efficacy rate of brachytherapy is not 100%. This cannot however be regarded as a major weakness of the therapy as the rescue rate identified by Hoskin et al. (2007) is relatively higher. Hoskin et al. (2007) however discover that depending on the variable of the population used, the results achieved were different. Regardless of the differences in results however, there has always been an improvement when analyzing the PSA, Gleason score and T stage for the exclusive use of brachytherapy. This means that the efficacy or rate of reoccurrence of the disease is more dependent on other factors such as type of disease and previous therapy received rather than the efficiency of the therapy on its own. Comparatively, Grado et al (1999) observes in a research that brachytherapy offers better hope and serves as a better alternative to other remedies for treating prostrate cancer such as radiotherapy. Because of this, modern practitioners advocate salvage brachytherapy alone. This however does not suggest that no other form of salvage therapy works because Grado et al (1999) found in their research that “the incidence of serious complications after salvage brachytherapy, such as incontinence and rectal complications, was lower than that reported after other types of salvage procedures.” The baseline of argument remains that salvage brachytherapy should always stand tall as complications associated with the use of salvage brachytherapy has always been minimal as compared to the hazard ratio (HR) associated with biochemical reoccurrence for most external procedure like radical prostatectomy and cryoablation (Vicini et al, 1998). Contraindications to Brachytherapy; with and without external therapies Medically, potency of a therapy such as the brachytherapy is judged by the positive impact it makes on beneficiaries though it is never denied that even in cases where therapies and medicines achieve needed results, they at times leave patients with dreadful side effects. For instance whether brachytherapy is used all alone or it is used in partnership with other therapies, there are some contraindications that are commonly experienced or identified. Some of these have been briefly discussed below. Prior transurethral resection of the prostate: Theodorescu (2011) alleges that initially treatment of prosprate cancer that relied on the use of external sources of treatment in addition to brachytherapy left transurethral resection of the prostate. The long term effect was that the situation led to increased urinary incontinence. In their research, Pieters et al (2006) ranked the percentage for this as 50%. However as modern scientific investigations encouraged the use of brachytherapy as a solitude treatment, incontinence rates have dropped to less than 10%. Pubic arch interference: Generally when the treatment of prostrate cancer is made to stand alone with the use of brachytherapy, there is bound to be interference but this interference depends on the size of the prostrate of gland >40 g(Aus, Hugosson and Norlen, 1995). More threatening is the fact that “this interference may preclude adequate placement of seeds” (Theodorescu (2011). High-Dose-Rate Brachytherapy: This is a more alarming contraindication with the use of brachytherapy on a temporary basis. This is because temporary brachytherapy comes with iridium (Ir) of192, which results in higher dose of iodine-125 radiation than ordinary and normal permanent implants. The risk becomes even more with the introduction of a third party or external therapy because such therapy or treatment also comes with its own radiation effects (Franks and Duch, 1999). Conclusion The beauty of science and for that matter medicine is the ability to discover, implement, improve and disprove where necessary. It is therefore very important that discoveries such as the brachytherapy exists. However, constant research and studies on the upgrading and modification of the therapy to meet modern standards and needs should not seize. With constant improvements, brachytherapy will come to be more and more useful in the treatment of prostrate cancer because all factors that are associated as risk factors will be identified and eventually eradicated. REFERENCE LIST Agency for Healthcare Research and Quality, 2008, ‘Comparative Effectiveness of Therapies for Clinically Localized Prostate Cancer. AHRQ: Agency for Healthcare Research and Quality’, Accessed November 23, 2011 Aus G, Hugosson J, Norlen L. Need for hospital care and palliative treatment for prostate cancer treated with noncurative intent. J Urol. 1995;154(2 pt 1):466-469. Chodak GW,Thisted RA, Gerber GS, et al. Results of conservative management of clinically localized prostate cancer. N Engl J Med. 1994;330:242-248. Franks L, Duch M. Latent progression in tumors: the natural history of prostate cancer. Lancet. 1956;2:1037-1039. Grado et al., 1999, ‘Salvage brachytherapy for localized prostate cancer after radiotherapy failure’ Urology. 1999 Jan;53(1):2-10. Hoskin et al., 2007, ‘High dose rate brachytherapy in combination with external beam radiotherapy in the radical treatment of prostate cancer: initial results of a randomised phase three trial’ Radiotherapy and Oncology 84 (2007) 114–120. Pieters et al., 2009, ‘Comparison of three radiotherapy modalities on biochemical control and overall survival for the treatment of prostate cancer: A systematic review’ Radiotherapy and Oncology 93 (2009) 168–173. Pieters et al., 2006, ‘Minimal displacement of novel self-anchoring catheters suitable for temporary prostate implants’ Radiotherapy and Oncology 80 (2006) 69–72. Pieters et al, 2008, ‘Comparison of biologically equivalent dose–volume parameters for the treatment of prostate cancer with concomitant boost IMRT versus IMRT combined with brachytherapy’, Radiotherapy and Oncology 88 (2008) 46–52 Vicini FA, Horwitz EM, Kini VR, Stromberg JS, Martinez AA. Radiotherapy options for localized prostate cancer based upon pretreatment serum prostatespecific antigen levels and biochemical control: a comprehensive review of the literature. Int J Radiat Oncol Biol Phys 1998;40:1101–10. Theodorescu D., 2011, ‘Prostate Cancer - Brachytherapy (Radioactive Seed Implantation Therapy)’, Medscap, Accessed November 23, 2011 Read More
Cite this document
  • APA
  • MLA
  • CHICAGO
(“Brachy therapy for prostate cancer Essay Example | Topics and Well Written Essays - 1250 words”, n.d.)
Brachy therapy for prostate cancer Essay Example | Topics and Well Written Essays - 1250 words. Retrieved from https://studentshare.org/health-sciences-medicine/1585058-brachy-therapy-for-prostate-cancer
(Brachy Therapy for Prostate Cancer Essay Example | Topics and Well Written Essays - 1250 Words)
Brachy Therapy for Prostate Cancer Essay Example | Topics and Well Written Essays - 1250 Words. https://studentshare.org/health-sciences-medicine/1585058-brachy-therapy-for-prostate-cancer.
“Brachy Therapy for Prostate Cancer Essay Example | Topics and Well Written Essays - 1250 Words”, n.d. https://studentshare.org/health-sciences-medicine/1585058-brachy-therapy-for-prostate-cancer.
  • Cited: 0 times

CHECK THESE SAMPLES OF Brachy therapy for prostate cancer

Dynamic Nuclear Polarization MRI

Dynamic Nuclear Polarization MRI Introduction: The research paper at hand focuses on MRI, in specific terms with dynamic nuclear polarization MRI.... First, the paper will define MRI and dynamic nuclear polarization, and then it will talk about the relation between the two.... hellip; Next it will give a history about the development as well as uses of MRI, that is, in terms of how much it has been beneficial in various fields....
8 Pages (2000 words) Essay

Robotic Cyberknife in the Medical Field

A Cyberknife is an innovative frameless robotic radiosurgery system that is based on the original concept of the old technology of the frame based radiosurgical system (Yarbo, Barbara, & Gobel, 297).... For twenty year of technical development alterations, Cyberknife Robotic… The Cyberknife consists of three components; a robot, an advanced light weight LUNAC and X-ray came as (Yarbo, Barabara, & Gobel, 297)....
7 Pages (1750 words) Research Paper

Prostate Cancer

ng/ml for… PSA may or may not be the valid marker for prostate cancer in the second screening, but the authors call for primary practicable preventive interventions during the intervals.... The Case for prostate cancer Screening with Prostate-Specific Antigen.... PSA may or may not be the valid marker for prostate cancer in the second screening, but the authors call for primary practicable preventive interventions during the intervals....
2 Pages (500 words) Annotated Bibliography

Quality of Life Intervention for Prostate Cancer Patients

Quality of life intervention for prostate cancer patients: design and baseline characteristics of the active for life after cancer trial.... 01. This article suggests that patients living with prostate cancer at the same time receiving androgen ablation therapy go through psychological and physical screech, which come as a result of their medical condition The article goes further to suggest that physical activities are crucial at this point because they improve one's psychological and physical well being....
6 Pages (1500 words) Annotated Bibliography

Differences of Acute Prostatitis, Benign Prostatic Hypertrophy, and Prostate Cancer

prostate cancer does not cause any signs at all and can present at any level of the illness.... The prostate cancer presents in urinary tract obstruction (LUTS) symptoms.... In regard to diagnostic testing, prostate cancer is diagnosed using imaging techniques such as MRI to detect tumors that are clinically significant.... atients suffering from prostate cancer are treated using a combination therapy of radiation and hormone therapy that is referred to as androgen deprivation therapy (ADT)....
2 Pages (500 words) Essay

Acute Prostatitis Illness

The risk factors for prostate cancer include lack of physical exercise, obesity, ethnicity and smokers are at greater risk than nonsmokers (Ellsworth, 2012).... The diagnostic tool used for prostate cancer is prostate-specific antigen (PSA), digital rectal assessment, trans-rectal ultrasound and prostate biopsy (Ramon & Denis, 2007).... agree that prostate cancer is the most killer disease in men.... Some risk factors cannot be managed for example family history of prostate cancer, race and family (Kazer & Powel, 2002)....
3 Pages (750 words) Essay

Effective and Ineffective adds

The copy reading about the prostate cancer in men is in the right direction but has much noise in it.... One may think that the cancer is only for those who put on Jeans Trouser.... For an advertisement to be effective, it has to pass through five stages of the creative pyramid....
2 Pages (500 words) Essay

Prostate Cancer

This coursework "prostate cancer" focuses on understanding the disease, causes, symptoms, diagnosis, treatment, and control.... However, prostate cancer has shown to increase virulence depending on age.... In the end, there is a conclusion about the disease and various initiatives that can help in controlling and treatment of prostate cancer.... nalysis of the prostate helps in understanding prostate cancer.... prostate cancer occurs because of the defect of gland cells in the prostate gland (American Cancer Society, 2014)....
6 Pages (1500 words) Coursework
sponsored ads
We use cookies to create the best experience for you. Keep on browsing if you are OK with that, or find out how to manage cookies.
Contact Us